GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Samsung Biologics Co rises 2.11% in Tuesday's session

Published by Global Banking & Finance Review

Posted on November 3, 2026

1 min read
Add as preferred source on Google
207940.KS 1,452,000.00 +2.11% last traded price, 3 Nov 2026
Previous close
1,422,000.00
Market cap
KRW 67.2tn

Source: Eulerpool. The figures in this article were checked against this snapshot before publication.

Samsung Biologics Co's shares last traded at 1,452,000 KRW, 2.11% above their previous close of 1,422,000 KRW on 3 November 2026. The company has a market value of $50.05bn in the South Korean health care sector.

Last traded price1,452,000 KRW
Previous close1,422,000 KRW
Change from the previous close+2.11%
Market value$50.05bn

Prices of Samsung Biologics Co (207940.KS), listed in South Korea, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 3 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 2 November 2026. Market value is converted to US dollars at the ECB reference rate. We report a stock the day it ends a session 2% or more away from its previous close, where the previous session's trading was worth at least US$5 million. Source: Eulerpool. How we compile these reports.

Samsung Biologics Co — daily KRX:207940

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Samsung Biologics Co on TradingView ↗

Related Articles

More from Markets

Explore more articles in the Markets category